sb 206553 has been researched along with sb 200646a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baxter, GS; Blackburn, TP; Booth, DH; Forbes, IT; Glen, A; Ham, P; Kennett, GA; Martin, RT; Thompson, M; Wood, MD | 1 |
1 other study(ies) available for sb 206553 and sb 200646a
Article | Year |
---|---|
5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity.
Topics: Administration, Oral; Animals; Indoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Pyridines; Rats; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin Antagonists | 1995 |